ArticleCureus2025
Diffuse Large B-Cell Lymphoma With Tracheoesophageal Fistula Healed Using Chemotherapy: A Case Report and Review of the Literature.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Malignant lymphomas are rarely associated with tracheoesophageal or bronchoesophageal fistulas (TEFs/BEFs). Lymphomas accompanied by TEFs/BEFs have a more favorable prognosis than solid tumors. Here, we present a unique case of a 74-year-old patient with diffuse large B-cell lymphoma (DLBCL). Contrast-enhanced computed tomography (CT) revealed TEF, aspiration pneumonia, and multiple lymphadenopathy. Histopathology helped confirm DLBCL, leading to a Lugano IIE staging. Complete DLBCL remission could be achieved by adjusting chemotherapy dosages for complications, which also resulted in spontaneous TEF resolution without requiring interventions such as stent insertion or surgical correction. No instances of lymphoma recurrence or tracheoesophageal fistula were observed 46 months post-chemotherapy. Among 33 documented cases, this is the first instance of DLBCL-associated TEF resolution through chemotherapy. Notably, in patients initially presenting with a fistula prior to treatment initiation, a favorable response to chemotherapy and/or radiotherapy coupled with controlled aspiration could potentially lead to the resolution of the fistula. Collectively, our case highlights the potential for conservative fistula management and the possibility of spontaneous resolution with chemotherapy. Our report provides valuable insights into lymphoma-associated fistulas and their management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.